SUNRAY-01
Phase 3 Recruiting
1,264 enrolled
REZILIENT2
Phase 2 Recruiting
220 enrolled
ASPECT
Phase NA Recruiting
90 enrolled
Study of the Disease Process of Lymphangioleiomyomatosis
Recruiting
2,000 enrolled
VALOR
Phase NA Recruiting
670 enrolled
Lung Ultrasound in Critically Ill Obstetrics and Gynecological Patients
Recruiting
64 enrolled
Role of Genetic Factors in the Development of Lung Disease
Recruiting
3,500 enrolled
ALKAZAR
Phase 3 Recruiting
450 enrolled
Advanced Imaging Holistic Omics Biobank
Recruiting
50,000 enrolled
CC1
Recruiting
2,000 enrolled
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer
Phase 2 Recruiting
15 enrolled
TELESCOPE-H
Phase NA Recruiting
91 enrolled
PALACE
Phase 2 Recruiting
63 enrolled
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Phase 2 Recruiting
170 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 2 FDA
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Phase NA Recruiting
100 enrolled
Early Intervention Strategies for Lung Cancer
Phase NA Recruiting
16,000 enrolled
Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients
Phase 2 Recruiting
72 enrolled
PET/CT GUIDED BIOPSY VERSUS CT GUIDED BIOPSY IN EVALUATION OF SUSPECTED LUNG NEOPLASMS
Phase NA Recruiting
108 enrolled
ARIAN
Phase 3 Recruiting
129 enrolled
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Recruiting
10,000 enrolled
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Phase NA Recruiting
2,996 enrolled
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Phase 1/2 Recruiting
53 enrolled
BernRehabReg
Recruiting
30,000 enrolled
PURE
Recruiting
200,000 enrolled
A Phase â…¡ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
Phase 2 Recruiting
62 enrolled